Intel and the University of Pennsylvania (UPenn) are training artificial intelligence models to identify brain tumours – with a focus on maintaining privacy.
The Perelman School of Medicine at UPenn is working with Intel Labs to co-develop technology based on federated learning, a machine learning technique which trains an algorithm across various devices without exchanging data samples.
The goal is therefore to preserve privacy. Penn Medicine and Intel Labs have claimed they were first to publish a paper on federated learning in medical imaging, offering accuracy with a trained model to more than 99% of a model trained in a non-private method. Work which will build on this, according to the two companies, will ‘leverage Intel software and hardware to implement federated learning in a manner that provides additional privacy protection to both the model and the data.’
The two companies will be joined by 29 healthcare and research institutions from seven countries.
“AI shows great promise for the early detection of brain tumours, but it will require more data than any single medical centre holds to reach its full potential,” said Jason Martin, principal engineer at Intel Labs in a statement.
Artificial intelligence initiatives in healthcare continue apace. Microsoft recently announced details of a $40 million ‘AI for Health’ project, while last month startup Babylon Health stated its belief that it can appropriately triage patients in 85% of cases.
Read the full Intel announcement here.
Interested in hearing industry leaders discuss subjects like this? Attend the co-located 5G Expo, IoT Tech Expo, Blockchain Expo, AI & Big Data Expo, and Cyber Security & Cloud Expo World Series with upcoming events in Silicon Valley, London, and Amsterdam.